Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Samuel S. K. Lam"'
Publikováno v:
Cells, Vol 10, Iss 3, p 492 (2021)
Ablation therapies have emerged as an effective tool for destroying cancerous tissue, but for advanced and disseminated tumors their application remains mainly a palliative measure. However, it is becoming increasingly clear that this limitation can
Externí odkaz:
https://doaj.org/article/46b4c309492d4ea88c80a267dcb6c7fd
Autor:
Ashley R. Hoover, Sunil More, Kaili Liu, Connor L. West, Trisha I. Valerio, Coline L. Furrer, Ningli Yu, Crystal Villalva, Amit Kumar, Lu Alleruzzo, Samuel S. K. Lam, Tomas Hode, Meng Zhao, James F. Papin, Wei R. Chen
Mucosal vaccinations for respiratory pathogens provide effective protection as they stimulate localized cellular and humoral immunities at the site of infection. Currently, the major limitation of intranasal vaccination is using effective adjuvants c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c7ff3e78f2032c2cb76dff6f32ccc38
https://doi.org/10.1101/2022.09.07.506979
https://doi.org/10.1101/2022.09.07.506979
Autor:
Samuel S K, Lam, Feifan, Zhou, Tomas, Hode, Robert E, Nordquist, Luciano, Alleruzzo, Joseph, Raker, Wei R, Chen
Publikováno v:
Discovery medicine. 19(105)
Since the invention of Coley's toxin by William Coley in early 1900s, the path for cancer immunotherapy has been a convoluted one. Although still not considered standard of care, with the FDA approval of trastuzumab, Provenge and ipilimumab, the medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4144dfa1aacd49714535ecb589b94d5d
https://pubmed.ncbi.nlm.nih.gov/25977192
https://pubmed.ncbi.nlm.nih.gov/25977192
Autor:
Matthew D. Vesely, Arlene H. Sharpe, Mireille Toebes, James P. Allison, Etienne Caron, Willem Jan Krebber, Cornelis J. M. Melief, Xiuli Zhang, Ton N. Schumacher, Jeffrey P. Ward, Matthew M. Gubin, Gordon J. Freeman, Jasreet Hundal, Samuel S. K. Lam, Takuro Noguchi, Heiko Schuster, Erika L. Pearce, Maxim N. Artyomov, Yulia Ivanova, Gwenn E. Mulder, Hans-Georg Rammensee, Alan J. Korman, Ruedi Aebersold, William E. Gillanders, Robert D. Schreiber, Cora D. Arthur, Elaine R. Mardis
Publikováno v:
Nature
Nature, 515(7528), 577
Nature, 515(7528), 577
The immune system influences the fate of developing cancers by not only functioning as a tumour promoter that facilitates cellular transformation, promotes tumour growth and sculpts tumour cell immunogenicity1,2,3,4,5,6, but also as an extrinsic tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::746fac9a63282cf9308a484b04d991d8
https://hdl.handle.net/1887/104264
https://hdl.handle.net/1887/104264
Autor:
Robert D. Schreiber, Jörn C. Albring, Harinder Singh, Leslie A. Weiss, Cora T. Aurthur, Samuel S. K. Lam, Elke Glasmacher, Nicole M. Kretzer, Michael S. Behnke, Wei Liao, Theresa L. Murphy, Xiaodi Wu, Ansuman T. Satpathy, Mona Mashayekhi, Wan-Ling Lee, Peng Li, Kenneth M. Murphy, L. David Sibley, Christina L. Stallings, Wumesh Kc, Roxane Tussiwand, Jeffrey A. Rotondo, Warren J. Leonard, Brian T. Edelson
Publikováno v:
Nature
The AP1 transcription factor Batf3 is required for homeostatic development of CD8α(+) classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens. Here we identify an alternative, Batf3-independent pathway in mice for C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dba17437d0aadf83d0b879a6a686959
https://pubmed.ncbi.nlm.nih.gov/22992524
https://pubmed.ncbi.nlm.nih.gov/22992524